Playbook › Themes
Health tech & healthcare software
Claim
Nine fields were swept across the July rounds. This one produced the only in-zone name. That is the finding — not DOCS specifically, but where the survivor came from.
DOCS — conviction 7.0, in entry zone. The top recommendation from the whole exercise,
and /analyze DOCS was offered but never run. Nothing here has been through a full
pipeline; this is screen-tier work only.
Why this field and not the others
Every field that participated in the 2024–26 AI run-up came back expensive on its own band ([[pattern-ai-levered-fields-trade-above-own-band]]). The three July survivors — DOCS (health tech), ZBRA (industrial scanning), NTES (China internet) — share exactly one property: none of them are AI-narrative-levered.
That is the transferable result. When a whole complex is above its own band, the value is in the fields the narrative skipped, not in the least-expensive member of the narrative.
⚠️ Confidence cap
medium, because DOCS has had a screen-tier health check only. VEEV was covered earlier
(March/June) and rejected as "great moat, 28x P/FCF — not deep value", so the field's
one prior look also ended in a price rejection.
What would falsify this
A full /analyze on DOCS finding the screen-tier valuation didn't survive scrutiny. Until
that's run, the conviction number is provisional.
History
- 2026-07-29 — swept in round 2; DOCS the exercise's single in-zone name.